Evidence for spinal facet joint injections remains limited
A review of randomized trials found low-certainty support for injections into spinal facet joints, without reporting a pooled estimate of patient benefit in the abstract.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review judged the evidence supporting injections into spinal facet joints to be limited and uncertain. Its abstract does not report how much pain or function improved compared with control treatments. The conclusion therefore concerns the strength of the evidence, rather than providing a clear estimate of how likely an individual patient is to benefit.
The authors identify a shortage of high-quality research. Abstract-only access also leaves the trial comparators, pooled treatment effects and actual follow-up durations unavailable.
What the review asked
The researchers evaluated injections delivered directly into facet joints as a treatment for chronic spinal pain arising from those joints. Their main outcome required substantial improvement in both pain and function that persisted beyond the immediate treatment period.
Why the certainty matters
Quality assessments differed across the methods used in the review. Although some assessment tools classified trials favorably, the final evidence synthesis assigned low certainty and a weak recommendation. That uncertainty does not establish either reliable benefit or treatment ineffectiveness.
The original publication
A Systematic Review And Meta-Analysis Of Randomized Trials Of Therapeutic Intraarticular Facet Joint Injections In Chronic Axial Spinal Pain.
Manchikanti L, Knezevic E, Sic A et al.
Pain Physician · 2025
- PubMed ID
- 40773633
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.